ITGAM and neoplasm: Metformin enhances the shift from an M2 to an M1-like phenotype accompanied by a significant reduction in reactive oxygen species (ROS) and glucose uptake in CD11b+ Gr-1low F4/80high TAMs, enhancing tumor inhibition [61,67].